Pfizer transfers certain medicines to Mylan as part of an agreement
The consideration for the medicines in India is valued at Rs 180.48 crore
The consideration for the medicines in India is valued at Rs 180.48 crore
The state-of-the-art facility provides a pathway from development to large-scale biologics production
A total of 707 district hospitals across all states and union territories participated in the performance assessment. The Health Management Information System (HMIS) data for the year 2017–18 has been used as a baseline for this exercise
The global wellness market is valued at more than US $ 1.5 trillion, with annual growth of 5-10 per cent
The listings aim to address global health priorities, identifying the medicines that provide the greatest benefits, and which should be available and affordable for all
Fortis Memorial Research Institute is the only hospital in India and South Asia to acquire the machine
The cloud-based platform enables long-term brain monitoring towards personalized treatment
These pouches, manufactured at UFlex India plant, will be exported to American markets and will be majorly used for packing edible products
The BLA is being submitted under the accelerated approval pathway and is primarily based on clinical, biomarker and safety data from the Phase 2b clinical trial in people with early AD and confirmed amyloid pathology
The CAC solution cleared by the U.S. FDA analyses already existing non-gated CT scans and quantifies the coronary artery calcium in order to identify, stratify, and facilitate treatment pathways for patients with cardiovascular disease
Subscribe To Our Newsletter & Stay Updated